A fully automatic method to register the prostate gland on T2-weighted and EPI-DWI images. by De Luca, M et al.
A Fully Automatic Method to Register the Prostate Gland on
T2-weighted and EPI-DWI images
Massimo De Luca, Valentina Giannini, Anna Vignati, Simone Mazzetti, Christian Bracco,
Michele Stasi, Enrico Armando, Filippo Russo, Enrico Bollito, Francesco Porpiglia, Daniele Regge
Abstract— Prostate adenocarcinoma (PCa) is the most fre-
quent noncutaneous cancer among men in developed coun-
tries. Magnetic Resonance (MR) has been used to detect
PCa and several clinical trials report on the accuracy of the
test. Multiparametric MR imaging (mpMRI) is defined as
the integration of information from different morphological
and functional datasets. mpMRI could be used to increase
the performances of prostate MR, therefore allowing a more
accurate assessment of the tumor gland extent, while reducing
reporting time and interobserver variability. The first step
to perform such a multiparametric analysis is to correct for
voluntary and involuntary movements during the acquisitions,
as well as for image distortion in the Diffusion Weighted (DWI)
images. The aim of this work is to present a fully automatic
registration algorithm between T2w and DWI images, able
to realign the images and to correct the distortions in the
DWI. Results showed a good overlap after registration and
a strong decrease of mean surface distance in both the central
gland and peripheral zone. These promising results suggest
that the algorithm could be integrated in a CAD system
which will combine the pharmacokinetic parameters derived
from DCE-MRI, T2w MRI and DWI MR to generate one
comprehensive value assessing the risk of malignancy. However
to perform such a multiparametric analysis, it is necessary to
correct for voluntary and involuntary (breathing, heart beating)
movements during the DCE-MRI acquisition, and to realign
also the DCE-MRI sequence to the T2w sequence.
I. INTRODUCTION
Prostate adenocarcinoma (PCa) is the most frequent non-
cutaneous cancer among men in developed countries. The
2007 report from the American Cancer Society projected
218,890 new cases of prostate cancer and 27,050 additional
deaths due to the disease in the United States [1] and its
incidence is increasing because of the aging population.
Since the advent of the prostate-specific antigen (PSA) era,
wider screening has led to an increasing proportion of men
with an elevated PSA but a negative digital rectal examina-
tion (DRE) [2]. Transrectal ultrasound (TRUS)-guided core
prostate biopsies are being used routinely to systematically
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sample the entire gland in patients with abnormal DRE
and/or elevated PSA in the search for prostate cancer and
the histopathologic examination of biopsy tissue remains the
gold standard for diagnosing prostate cancer. However, the
sensitivity and specificity of TRUS in diagnosing impalpa-
ble prostate cancer still remains low: the number of false
negatives in a single sextant biopsy session reported ranges
between 30 and 45% [3]. Limitations of traditional screening
methods are stimulating research in the field of diagnostic
imaging, because accurate tumor detection, localization, and
staging may critically influence the choice of treatment,
radical (prostatectomy, hormone ablation, radiotherapy) ver-
sus local, minimally invasive therapies (cryoablation, ra-
diofrequency ablation, focused ultrasound) that can improve
quality of life without compromising oncologic outcome.
Some patients with low-risk prostate cancer may also be
candidates for the watchful waiting approach. While diag-
nostic T2-weighted (T2w) MRI images are a sensitive non-
invasive imaging technique for detecting focal abnormalities
in the prostate, they lack specificity distinguishing between
tumor and benign prostatic hyperplasia (BPH) and other
abnormalities. In fact, it is reported that T2w MR has
a specificity of 43%, and a sensitivity of 85% for non-
palpable, posteriorly located tumors [4]. Thus, there is a need
to improve the image-based specificity to diagnose cancer
and to integrate information from other MR methodologies
or imaging modalities. An alternative to T2w MRI is to
develop image contrast through “apparent diffusivity” (tissue
water incoherent displacement over distances of 1–20 mm).
Diffusion-weighted (DWI) magnetic resonance imaging has
been used in both clinical and research settings for detecting
cerebral pathologies [5]. Recently, reports of the utility of
DWI in prostate cancer [6], [7] have been presented. The
extensive branching ductal structure of the normal prostate
compared with the highly restricted intracellular and in-
terstitial spaces encountered in prostate cancers produces
a substantial differential in apparent diffusion coefficient
(ADC), and thus the potential for high image contrast. DWI
MR has extreme sensitivity to motion and, consequently, re-
quires ultrafast imaging techniques. With the recent advances
in MR hardware development, particularly fast gradient
coils, single-shot echo planar imaging (EPI) emerged as a
technique of choice for diffusion measurements in intra-
abdominal organs as well as the prostate gland. With EPI
sequence an image is acquired within a single shot, the
duration of which is typically around 100 msec, and hence
motion is effectively frozen during the acquisition. EPI, how-
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ever, is affected by geometric distortions and chemical shift
artifacts caused by the susceptibility effects. These effects
are due to the air-filled balloon surrounding the endorectal
coil and poor local B0 homogeneity which leads to pixel
shifts, particularly in the phase encode direction. Jezzard
[8] proposed a method to correct geometric distortion which
requires the measure of the magnetic field map inside the
FOV with the object to scan in place. Such a field map will
include the effects of inhomogeneities of the main magnetic
field and varying tissue susceptibility, then values from the
field map can then be compared with the expected values
and the distortion calculated and corrected. This method
achieved good performance but is difficult to implement in
normal clinical practice. Other methods are semi automatic
and require the manual placement of control points on both
T2w and DWI images [6], [7]. The aim of this work is
to present a new fully automatic method to register T2w
and EPI-DWI images which does not require the estimation
of the static magnetic field and which is based on the
automatic segmentation of the bladder and the endorectal
coil. Bladder and endorectal coil are well-defined structures
in both T2 and DWI and are easy to segment, while automatic
prostate segmentation is challenging due to the heterogeneity
of this anatomical region. This registration algorithm could
be integrated in a computer aided diagnosis (CAD) system
which will combine the pharmacokinetic parameters derived
from DCE-MRI with information coming from T2w MRI
and DWI MR to generate one comprehensive value assessing
the risk of malignancy. This multiparametric analysis has
recently been proven to be useful [9], but its performance
strictly relies on an accurate registration between DWI MR
and other MR modalities.
II. MATERIALS AND METHODS
A. MRI Protocols
DWI MR data were acquired on 12 patients using a single-
shot EPI sequence with the following parameters: FOV=16
cm, slice thickness 3 mm, BW=62.50 kHz, TR=6275
ms, TE=min, flip angle=90, 128x128 matrix, b-value=600
s/mm2, NEX=6, 24 slices. Apparent diffusion coefficient
(ADC) values were calculated from two DWI images ac-
quired with b-value=0 s/mm2 and 600 s/mm2. The ADC
maps were reconstructed by calculating the ADC values in
each pixel of each slice.
B. Database Development
In order to validate the proposed registration method, the
peripheral zone (PZ), the central gland (CG) and the whole
prostate gland (TOT) were manually drawn by a radiologist
on both DWI and T2w images. In Fig. 6 are shown, both
superimposed on the T2w image, the outlines of PZ and CG
binary masks drawn on DWI (red line) and the outlines of
the same regions drawn on the T2w (green) before (Fig.
6a) and after (Fig. 6b) the application of the registration
method. Two performance indexes were calculated before
and after registration: the overlap index (OI), defined as the
ratio between intersection and union of the masks, and the
Fig. 1: a) Bladder on DWI image. b) Segmented bladder on
DWI. c) Stripe around bladder wall on DWI d) Bladder on
T2w image. e) Segmented bladder wall on T2w image.
mean surface distance (MSD). A total of 12 patients were
included in this study, 4 exams were used as training set in
order to find the optimal decreasing displacement rate (k in
(1)) maximizing the overlap index, then the algorithm was
validated on the remaining 8 exams. A t-test is performed
to evaluate the p values between OI and MSD values before
and after registration. The null hypothesis is that there is
no difference between OI and MSD values before and after
registration, with a significance level of 0.05.
C. Methods
The entire registration procedure involves two major steps.
First, an affine transform is estimated by a segmentation-
based method. In this step the bladder is automatically
segmented in the DWI image by a watershed algorithm
applied on the apparent diffusion coefficient (ADC) map,
where it is well visible because of its high water content. The
watershed is computed over the gradient magnitude image
and proceeds in several steps. First, an initial classification
of all points into catchment basin regions is done by tracing
each point down its path of steepest descent to a local min-
ima. Next, neighboring regions and the boundaries between
them are analyzed according to a saliency measure, which
is, in this case, the minimum boundary height, to produce a
tree of merges among adjacent regions. Then, excluding the
background, the bladder is the biggest region obtained with
an absolute minimum height percentage of 10% and a depth
of the catchment basin of 30%. As the bladder segmentation
on DWI is obtained, morphological erosion and dilation are
applied to extract a stripe around the border of the bladder
(Fig. 1c). The stripe thickness is 20 mm, so it always includes
the bladder wall also on the T2w image. Pixels belonging to
this stripe on the T2w image were classified by a k-means
cluster in two groups according to their intensity values, and
the segmentation of the bladder wall is obtained, as is shown
in Fig. 1e.
Then bladder border points on the T2w and DWI are
extracted from the binary masks (Fig. 2) and coupled using
the iterative closed points (ICP) algorithm (Fig. 3) in the
slice where the bladder reaches its biggest area. The coupled
points are used to find, by a least squares fitting, the affine
transform parameters and then the transformation is applied
on the whole DWI image.
The affine transform computed in the previous step can
correct possible shearing, translational and scaling artifacts
mainly caused by motion or by eddy currents (residual
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(a) (b)
Fig. 2: Segmented bladder on the DWI image (a) and T2
image (b).
(a) (b)
Fig. 3: Some of the bladder border points matched with ICP
on DWI (a) and T2W (b) images.
gradient field) formed in presence of a changing magnetic
field [10], but do not correct non-linear geometric distortion
caused in large part by static magnetic field inhomogeneities
near the coil, and which is a major concern because most
prostate tumors are localized in the peripheral zone. There-
fore the first rigid registration step is refined with a non-
rigid registration step based on the coil segmentation. The
coil is segmented both in T2w and DWI images by a region
growing algorithm, starting from a seed point inside the coil
which is automatically found by a circular Hough transform.
Then, for each slice where the coil is visible, two spline
smoothing curves are fitted on the coil border points on the
DWI and T2w images and used to estimate the displacement
near the coil surface (Fig. 4). The initial displacement is
estimated as the difference between the upper points of these
spline curves, as shown in Fig. 4. Therefore the deformation
field T is modeled as a piecewise linear decay field along
the vertical direction (Eq. 1), assuming that the pixel shifts
caused by magnetic field inhomogeneities occur particularly
in the phase encode direction [8] and decrease linearly with
distance from the coil.
T (x) = 0
T (y) =
{
di − k ∗ y 0 < y < dik
0 y > dik
(1)
where the coordinate system is shown in Fig. 4. The de-
creasing rate of the vertical displacement k in (1) was chosen
maximizing the overlap index described in the following
section on a training set. Then the estimated deformation
Fig. 4: Spline curves superimposed on DWI (left) and T2w
(right), and initial displacement between DWI and T2w near
the coil.
(a) (b) (c)
Fig. 5: a) Prostate on T2 image. b) Deformation field
superimposed on DWI. c) Deformation field applied on DWI.
field T is applied to the DWI in order to correct the geometric
distortion (Fig. 5).
III. RESULTS
Table I reports the MSD values and Table II the OI
values for CG, PZ and TOT before and after registration.
P-values for MSD measurements for CG, PZ and TOT are
respectively 0.017, 0.0018 and 0.0014, while p-values of
OI measurements are 0.015, 0.0004 and 0.0001 respectively.
All p-values are smaller than the significance level, showing
that the OI and the MSD obtained before registration are
statistically different from those obtained after registration.
IV. DISCUSSION
In this study we presented an automatic registration algo-
rithm able to correct misalignment between T2w and DWI
MR images, due to a) incorrect determination of the reso-
nance frequency by the scanner in some measurements lead-
ing to a “rigid body” shift in the phase-encoding direction
of the echo planar images, b) susceptibility inhomogeneities
resulting in irregular distortions, e.g. proximal to rectal wall
at the air-tissue interface, and c) voluntary and involuntary
patients movements during the acquisition. To the best of
our knowledge there are no methods in literature addressing
this problem in an fully automatic way. De Souza et al. [6]
corrected the displacement by shifting the DWI images ac-
cording to the amount of displaced center of mass, manually
calculated. Automatic methods have the potential of reducing
inter- and intra-observer variability and reading time, and
could be integrated in a fully automatic CAD system for
prostate cancer detection and diagnosis. One limitation of
this method is represented by the choice of the parameters
for the piecewise linear decay modeling. These parameters
are heuristic constants chosen in order to obtain the best
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TABLE I: MSD for CG, PZ, TOT zones pre- and post- registration. ∆ represents the % difference between the MSD pre
and post registration.
CG pre PZ pre TOT pre CG post PZ post TOT post ∆ CG ∆ PZ ∆ TOT
mm mm mm mm mm mm
Patient 1 0.54 2.40 0.50 0.13 1.10 0.14 -76% -54% -72%
Patient 2 0.46 3.90 0.58 0.12 1.38 0.15 -74% -65% -74%
Patient 3 0.64 1.54 0.66 0.23 0.29 0.13 -64% -81% -80%
Patient 4 0.34 1.85 0.59 0.25 0.71 0.26 -26% -62% -56%
Patient 5 1.36 0.16 1.33 0.25 0.12 0.12 -82% -25% -91%
Patient 6 0.63 0.91 0.29 0.76 0.46 0.15 21% -49% -48%
Patient 7 0.30 2.45 0.65 0.13 0.20 0.11 -57% -92% -83%
Patient 8 0.47 1.50 0.55 0.18 0.45 0.10 -62% -70% -82%
Mean 0.59 1.84 0.64 0.26 0.59 0.15 -52% -62% -73%
Std. dev. 0.33 1.12 0.30 0.21 0.44 0.05 34% 20% 14%
TABLE II: OI for CG, PZ, TOT zones pre- and post- registration. ∆ represents the % difference between the OI pre and
post registration.
CG pre PZ pre TOT pre CG post PZ post TOT post ∆ CG ∆ PZ ∆ TOT
Patient 1 0.70 0.27 0.73 0.84 0.51 0.85 20% 89% 16%
Patient 2 0.70 0.28 0.70 0.84 0.53 0.83 20% 89% 19%
Patient 3 0.59 0.36 0.66 0.75 0.68 0.83 27% 89% 26%
Patient 4 0.73 0.32 0.65 0.71 0.58 0.71 -3% 81% 9%
Patient 5 0.41 0.21 0.51 0.79 0.69 0.84 93% 229% 65%
Patient 6 0.72 0.53 0.79 0.72 0.57 0.84 0% 8% 6%
Patient 7 0.74 0.32 0.71 0.79 0.73 0.85 7% 128% 20%
Patient 8 0.70 0.46 0.71 0.80 0.63 0.86 14% 37% 21%
Mean 0.66 0.34 0.68 0.78 0.62 0.83 22% 94% 23%
Std. dev. 0.11 0.10 0.08 0.05 0.08 0.05 30% 66% 18%
(a) (b)
Fig. 6: Manual prostate gland segmentation drawn on
DWI(red) and T2 (green) superimposed on T2, before regis-
tration (a) and after registration(b)
performance on the training set. Future works should include
the choice of such parameters based on a optimization step,
i.e. including mutual information, in order to obtain more
reproducible results and better generalize the problem. In
conclusion, we presented a method to automatically register
images coming from two different datasets (T2w and DWI),
and results showed a good overlap after registration and
a strong decrease of mean surface distance in both the
central gland and peripheral zone, 0.26 mm and 0.59 mm
respectively. Other studies in literature obtained a mean
distance of 1.2 mm [6] in a semi-automatic way, or 0.5 mm
[8], by calculating the RMS field inhomogeneity variations.
The algorithm should be certainly tested on a larger dataset,
but its promising results suggest that it could be integrated
in a CAD system which will combine the pharmacokinetic
parameters derived from DCE-MRI, T2w MRI and DWI MR.
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